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LACTOCOCCUS LACTIS STRAINS ENGINEERED TO IMPROVE 
GALACTOSE REMOVAL FROM DAIRY PRODUCTS REVEAL 













This study aimed at engineering Lactococcus lactis to improve its galactose 
fermenting capacity. Although several galactose-PTS systems have been described 
in other bacteria, L. lactis NZ9000 consumes galactose mainly via the Leloir 
pathway using GalP as the permease. α-Phosphoglucomutase appeared to be a key 
enzyme in controlling the galactose metabolic flux through the Leloir pathway, since 
galactose-1-phosphate and glucose-1-phosphate, the metabolites upstream of α-
phosphoglucomutase in the pathway, accumulate. Overexpression of genes 
encoding proteins of the Leloir pathway in L. lactis resulted in an even higher 
accumulation of these metabolic intermediates. Improved galactose consumption 
was achieved by overexpression of the galactose permease GalP together with α-
phosphoglucomutase from Streptococcus thermophilus, which removed one of the 
bottlenecks hampering efficient galactose consumption. Additionally, this work 
revealed that galactose can be transported in L. lactis by PTSlac, encoded by the 
plasmid pMG820-located lacFE, after which galactose is metabolized via the 
tagatose-6P-pathway, specified by the same plasmid. The overall glucose 
consumption rate using this route, however, is lower than when GalP and the Leloir 





Lactococcus lactis is a lactic acid bacterium widely used as a starter in the dairy 
industry for the production of fermented milk products. Because of its economic 
importance, L. lactis has been studied intensively for the last three decades. The 
metabolic potential of this organism is known to be relatively simple. Sugar 
catabolism involves sugar-specific phosphoenolpyruvate-dependent 
phosphotransferase systems (PEP:PTS), sugar permeases and catabolic enzymes, 
e.g. for glycolysis. PEP:PTSs catalyze the uptake and concomitant phosphorylation 
of a sugar. L. lactis is able to ferment the milk sugar lactose, which consists of a 
galactose and a glucose moiety. Lactose is imported and phosphorylated by a 
lactose-PTS system, and hydrolyzed to form glucose and galactose-6-phosphate 
(210). Glucose, the preferred sugar of L. lactis, is subsequently metabolized, while 
galactose-6-phosphate is dephosphorylated and expelled into the medium (141), a 
process that is probably caused by catabolite repression (198). When glucose has 
been metabolized, catabolite repression is relieved and galactose can be used.  
As a result of incomplete lactose utilisation, some fermented dairy products contain 
significant residual amounts of galactose, which can pose health problems. Human 
individuals having a deficiency in one of the enzymes of the Leloir pathway (GalK or 
GalT deficiencies are most common), are unable to metabolize galactose, which can 
result in a disease condition called galactosemia (97). This autosomal recessive 
genetic disorder leads to accumulation of galactose derivatives like galactitol, 
galactose-1-phosphate and UDP-galactose in the blood, creating serious health 
problems. Patients with galactosemia can suffer from cataracts in the eyes and 
ovarian failure, besides neurological problems like cerebral edema, progressive 
decline in IQ and speech difficulties (158, 172, 178). For these individuals milk 
fermentation products with lowered galactose contents are desirable, which could be 
achieved by constructing starter strains tailored to improve galactose utilization. 
In L. lactis galactose is imported by galactose permease (GalP), a secondary 
transport system that couples galactose uptake to ion translocation (54, 142). The 
imported galactose is further converted to glucose-1-phosphate (G1P) via the Leloir 
pathway (Fig. 1), which comprises steps catalyzed by galactose mutarotase (GalM), 
galactokinase (GalK), galactose-1-phosphate uridylyltransferase (GalT) and UDP-
galactose-4-epimerase (GalE), together converting galactose to G1P (54). The next 
step in galactose metabolism is a reversible reaction converting G1P to glucose-6-






































Figure 1: Schematic overview of the first steps in the metabolism of galactose by L. 
lactis.  
Galactose can be imported by a non-PTS system (GalP or possibly another non-PTS 
transporter indicated by the double questionmark) and metabolized to glucose-1-phosphate 
via the Leloir pathway and converted to glucose-6-phosphate by PgmH. Galactose may also 
be imported by a PTS (perhaps LacFE?) and further metabolized to triose-phosphates by the 
tagatose-6P-pathway. Triose-phosphates enter glycolysis. Abbreviations: GalP, galactose 
permease; GalM, galactose mutarotase; GalK, galactokinase; GalT, galactose-1-phosphate 
uridylyltransferase; GalE, UDP-galactose-4-epimerase; PgmH, α-phosphoglucomutase; 
LacFE, PTSlac; LacAB, galactose-6-phosphate isomerase; LacC, tagatose-6-phosphate 
kinase; LacD, tagatose-1,6-bisphosphate aldolase; UDP-gal/glc, UDP-galactose/glucose. The 
letter P at the end of a metabolite represents phosphate. 
 
 
The L. lactis MG1363 gal genes are clustered in an operon (galPMKTE) (54). The 
gene encoding α-phosphoglucomutase (α-PGM) of L. lactis MG1363 was not known 
until very recently, after the work described in this chapter was executed. 
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Lactococcal α-PGM turned out to be a very specific and unique enzyme in that it 
does not belong to the known family of prokaryotic α-phosphoglucomutases (this 
thesis, Chapter 5, (121)). Although the α-PGM from Escherichia coli encoded by 
pgmU has been successfully cloned in a metabolic engineering strategy to improve 
exopolysaccharide production in L. lactis (13), in this paper we used the α-PGM of 
Strestococcus thermophilus instead, since this lactic acid bacterium is generally 
regarded as save (GRAS) and it is a closer relative to L. lactis. 
Besides through the Leloir pathway, L. lactis can metabolize galactose via the 
tagatose-6-phosphate pathway (Fig. 1) (210). In this case, galactose uptake is 
mediated by a PEP:PTS, at the expense of one PEP molecule, leading to 
intracellular galactose-6-phosphate (Gal6P) (148, 187, 190). The PTSlac is 
suggested to be able to transport galactose (92, 135). Whether the Leloir pathway or 
the tagatose-6-phosphate pathway is primarily used, is strain-dependent (187). In L. 
lactis ssp. cremoris MG1363, the laboratory strain employed in this study, the Leloir 
pathway is used (54). 
This study aimed at engineering L. lactis to improve its galactose fermenting 
capacity, as a means to reduce the galactose concentration in dairy products to a 
minimum. Metabolic engineering strategies often entail the overexpression or 
deletion of genes operating in competing pathways or of regulator genes of the 
pathways, to produce a specific product or increase the use of a specific substrate 
(38). Engineering sugar pathways is often not straightforward, since sugar 
metabolism is a highly regulated process in which changes in the concentration of 
metabolic enzymes, and thus of one or more metabolite(s), may have unpredictable 
effects on the cell. For example, to obtain a higher galactose consumption in 
Saccharomyces cerevisiae, the gene regulatory network had to be engineered 
instead of the metabolic enzymes (131).   
To improve the efficiency of galactose metabolism in L. lactis, the different transport 
systems were investigated separately and the effects of overexpression of several 
galactose metabolic genes was examined using in vivo NMR. The knowledge thus 
gained about the bottlenecks in galactose metabolism allowed designing a 
successful strategy for the overexpression of genes that led to more efficient and 
more complete galactose utilization.  
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EXPERIMENTAL PROCEDURES  
 
Microbial strains used and growth conditions  
Strains and plasmids used in this study are listed in Table 1. The strains were grown 
at 30ºC in M17 broth (Difco, Sparks, MD) containing 1% (w/v) galactose or in 
chemically defined medium (CDM) (144) with 1% (w/v) galactose. When 
appropriate, erythromycin or chloramphenicol was used at 5 μg/ml. Nisin-induction 
of gene expression was performed by addition of supernatant (dilution 1:10,000) 
from a fully grown culture of the nisin producer L. lactis NZ9700 (82), when the cells 
to be tested reached an optical density at 600 nm of 0.5. For growth in a 2 L 
Biostat® MD fermentor (B. Braun Biotech, Inc., Allentown, PA), the medium was 
gassed with argon for 1 h prior to inoculation (4% inoculum from a culture grown 
overnight in the same medium); the pH was kept at 6.5 by automated addition of 5 M 
NaOH, while an agitation rate of 70 rpm was used. Growth was monitored by 
measuring the optical density at 600 nm in a Novaspec II spectrophotometer 
(Amersham Pharmacia Biotech., Uppsala, Sweden). 
 
TABLE 1: Strains, plasmids and primers used 
Strains Description Reference 
 
L. lactis 
MG1363 L. lactis subsp. cremoris, plasmid free derivative of NCDO712 (52) 
NZ9000 MG1363 carrying pepN::nisRK (84) 
NZ9700 Nisin producing transconjugant with the nisin-sucrose  
 transposon Tn5276 (82) 
LL302 RepA+ MG1363, carrying a copy of pWV01 repA in pepX (95) 
NZ9000ΔgalP NZ9000 with deletion of galP This work 
NZ9000ΔgalPMK NZ9000 with deletion of galPMK This work 
 
S. thermophilus  
ST11 Gal- strain (115) 
 
Plasmids Description Reference 
 
pNZ8048 CmR, nisin inducible PnisA (34) 
pNG8048e CmR, EmR, derivative of pNZ8048 Lab stock 
pORI280 EmR, LacZ+, RepA-, ori+  (96)  
pVE6007 CmR, Ts-ori, derivative of pWV01  (107) 
pMG820 23.7 kb derivative of pLP712, containing lacFEGABCD (106) 
pgalP pNG8048e, galP in the NcoI / XbaI site This work 
pgalPMKT pNG8048e, galPMKT in the NcoI / XbaI site This work 
ppgmA-ST pNG8048e, pgmA of S. thermophilus in the NcoI / XbaI site This work 
pgalP-pgmA-ST pgalP, pgmA of S. thermophilus  in the XbaI-site This work 




General DNA manipulations  
General DNA techniques were performed essentially as described (162). Plasmid 
DNA was isolated by the method of Birnboim and Doly (12). Restriction enzymes, T4 
DNA ligase, Expand polymerase and Taq DNA-polymerase were obtained from 
Roche Diagnostics GmbH (Mannheim, Germany) and used according to the 
supplier’s instructions. PCR amplifications were performed in an Eppendorf thermal 
cycler (Eppendorf, Hamburg, Germany) with L. lactis MG1363 chromosomal DNA as 
the template, unless described otherwise, using appropriate conditions. Primers 
used in this study are described in Table 2. 
 
 
Construction of galP and galPMKT overexpression vectors 
The PCR products obtained with primer pairs GalA1-fw / GalA-rev and GalA1-fw / 
GalT-rev were cloned as Eco31I / XbaI restriction fragments in NcoI / XbaI restricted 
pNG8048e, resulting in the plasmids pGalP (galP cloned downstream of the nisin-
inducible promoter PnisA) and pGalPMKT (galPMKT downstream of PnisA), 
respectively. The plasmids were introduced by electrotransformation (60) in L. lactis 
NZ9000 and L. lactis NZ9000[pMG820]. 
 
 
TABLE 2: Primers used in this study 
Name  Sequence (5’ to 3’), restrictionsite underlined Restriction sites 
 
GalA1-fw CGGTCTCCCATGAAAGAGGGAAAAATGAAACAACG Eco31I 
GalA-rev CTAGTCTAGATTATTTCAAACGTTCTTC XbaI 
GalT-rev CTAGTCTAGATTATTGATTCACAAAATC XbaI 
PgmA-ST-fw1 CATGCCATGGTAGTTGTGATACAATGTAAGCG NcoI 
PgmA-ST-fw2 GCTCTAGATAGTTGTGATACAATGTAAGCG XbaI 
PgmA-ST-rev GCTCTAGATTGGTGTAGCAGCGAAAG XbaI 
GalA-KO1 GCTCTAGACTTTCGGGAGAAACCGTGG XbaI  
GalA-KO2 CGGGATCCCCCTCTTTCATGGGAATCC BamHI  
GalA-KO3 CGGGATCCCCTTTGTAGTCCCAGCGG BamHI  
GalA-KO4 CGGAATTCGAATGCTATCTTCTCCACC EcoRI  
GalAMK-KO5 CGGGATCCGATGATTACGAAGTCACTGG BamHI  




Construction of galP and galPMK deletion strains 
The PCR products obtained with primer pairs GalA-KO1 / GalA-KO2 and GalA-KO3 
/ GalA-KO4 were cloned together as XbaI / BamHI and BamHI / EcoRI restriction 
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fragments in XbaI / EcoRI restricted pORI280 (96), resulting in pORI280-galP’. This 
plasmid was obtained using L. lactis LL302 (95) as the cloning host. PCR products 
obtained with primer pairs GalA-KO1 / GalA-KO2 and GalAMK-KO5 / GalAMK-KO6 
were cloned as XbaI / BamHI and BamHI / EcoRI restriction fragments in XbaI / 
EcoRI restricted pORI280, resulting in pORI280-galPMK’, which was obtained and 
maintained in L. lactis LL302. Introducing pORI280-galP’ or pORI280-galPMK’ 
together with helper plasmid pVE6007 in L. lactis NZ9000, followed by a two-step 
homologous recombination event (96), yielded strains NZ9000ΔgalP and 
NZ9000ΔgalPMK, respectively, the chromosomal structures of which were 
confirmed by PCR analysis and Southern blotting using Enhanced 
Chemiluminescence (ECL) detection (Amersham Pharmacia Biotech) with a PCR 
fragment obtained with primer pair galA-KO1 / galA-KO2 as a probe.  
 
 
Overexpression of pgmA  
To clone the pgmA gene of Streptococcus thermophilus ST11, primers were 
designed on the sequence of S. thermophilus LY03 (IMDST01, culture collection at 
VU, Brussels, Belgium). The PCR product obtained with primer pairs PgmA-ST-fw1 / 
PgmA-ST-rev was cloned as an NcoI/XbaI restriction fragment in NcoI/XbaI-
restricted pNG8048e, to obtain ppgmA-ST. The PCR product obtained with primer 
pairs PgmA-ST-fw2 / PgmA-ST-rev was cloned as an XbaI restriction fragment in 
XbaI-restricted pgalP or pgalPMKT, to obtain pgalP-pgmA-ST and pgalPMKT-pgmA-
ST, respectively. Variants of both plasmids that carried pgmA downstream and in 
the same orientation as the gal gene(s) were selected in L. lactis NZ9000. Plasmid 
constructions were checked by EcoRI restriction analysis.  
 
 
Determination of α-phosphoglucomutase activity in cell extracts  
Cell cultures grown to an OD600 of 0.5 were induced with nisin as described above. 
After 2 h of induction, a 20 ml sample was centrifuged (6000 rpm, 7 min), washed 
twice with potassium phosphate (KPi) buffer (5 mM, pH 7.2) and resuspended in 1 
ml KPi solution (10 mM, pH 7.2). Cells were disrupted using 0.5 g glass beads (∅ 
50-105 μm, Fischer Scientific BV, Den Bosch, the Netherlands), using a Mini-
BeadBeater-8 (Biospec products, Inc., Bartlesville, OK) with two 1 min pulses of 
homogenization, and a 1 min interval on ice. Cell debris was pelleted and α-
phosphoglucomutase specific activity was assayed as described before (150). The 
reaction mixture (250 μl) consisted of: TEA buffer (50 mM; pH, 7.2), 5 mM MgCl2, 
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0.5 mM NADP+, 0.5 U glucose-6-phosphate dehydrogenase, 50 μM glucose-1,6-
bisphosphate and cell extract (10-20 μl). After 2 min of incubation at 30ºC, the 
reaction was started by addition of 1.4 mM α-G1P. Enzymes were assayed at 30ºC 
in a 96 well microtiterplate using the GENios microtiterplate reader and Magelan 
software (Tecan, Grödig, Austria). One unit of enzyme is defined as the amount of 
enzyme catalyzing the conversion of 1 μmol of substrate (NADP+) per min under the 
assay conditions used. Specific activity was expressed as units (μmol·min-1) per 
milligram of protein. Measurements were done at 340 nm (NADPH absorbance 
peak). Protein concentrations were determined by the method of Bradford (19). 
 
 
In vivo NMR spectroscopy  
Cells were grown in a 2 L fermenter in CDM with 1% w/v galactose and harvested 
during mid-logarithmic phase (OD600 = 2.2), centrifuged, washed twice and 
resuspended to a protein concentration of approximately 15 mg/ml in 50 mM KPi 
buffer (pH 6.5). In vivo NMR experiments were performed using the on-line system 
described earlier (124). Specifically labeled galactose ([1-13C]-galactose) was added 
to the cell suspension to a final concentration of 20 mM at time-point zero. The time 
course of galactose consumption, product formation, and changes in the pools of 
intracellular metabolites were monitored in vivo. When the substrate was exhausted 
and no changes in the resonances of intracellular metabolites were observed, a total 
NMR-sample extract was prepared and used for the quantification of end-products 
and other metabolites (124, 127). The concentration of labeled lactate determined 
by 1H-NMR was used as a standard to calculate the concentration of the other 
metabolites in the sample (124). 
Due to the fast pulsing conditions used for acquiring in vivo 13C-spectra, correction 
factors were determined to convert peak intensities into concentrations (124). The 
correction factors for Gal1P (0.73), α-G1P (0.73), UDP-Gal (0.67) and UDP-Glc 
(0.67) were determined as follows: an NMR-sample extract supplemented with the 
pure compounds was circulated through the NMR tube at a rate similar to that used 
for cell suspensions and 13C-NMR spectra were acquired with a 60º flip angle and a 
recycle delay of 1.5 s (saturating conditions) or 60.5 s (relaxed conditions). The 
quantitative kinetic data for intracellular metabolites were calculated as described 
elsewhere (125, 127). The lower limit for in vivo NMR detection of intracellular 
metabolites under these conditions was 3-4 mM. Intracellular metabolite 
concentrations were calculated using a value of 2.9 µl/mg of protein for the 
intracellular volume of L. lactis (146). Carbon-13 spectra were acquired at 125.77 
Galactose metabolism 
91 
MHz on a Bruker DRX500 spectrometer (Karlsruhe, Germany). All in vivo 
experiments were run using a quadruple nuclei probe head at 30°C, as described 
before (124). Acquisition of 13C-NMR spectra was performed as described by Neves 
et al (127). Although individual experiments are illustrated in each figure, each 
experiment was repeated at least twice and the results were highly reproducible. 
The values reported are averages of two experiments and the accuracy varied from 
±2% (extracellular products) to ±10% in the case of intracellular metabolites with 





Galactose can be imported by L. lactis by more than one non-PTS 
permease and by a PTS system 
The first step in the utilization of substrates by L. lactis, i.e. transport across the cell 
membrane, is likely to have an important contribution to the overall sugar utilization 
rate. The first aim was to get an overview of which galactose transport systems are 
present in L. lactis and to determine the galactose consumption rate in strains using 
different galactose transport systems. The uptake of galactose in L. lactis is mainly 
mediated by the galP-encoded galactose permease (54). Since previous work had 
shown that galactose transport in an L. lactis MG1363 galP mutant was strongly 
reduced (54), a galP deletion was made in the isogenic strain NZ9000 
(MG1363pepN::nisRK) in order to block the Leloir pathway (Fig. 2) and study 
galactose consumption via a possible PTS by introducing pMG820 in the galP-
negative strain. Surprisingly, L. lactis NZ9000ΔgalP was still able to grow in a 
medium with galactose as the sole carbon source in a way comparable to wildtype 
L. lactis NZ9000. The maximum growth rate was only slightly decreased relative to 
that of NZ9000 (Fig. 2). Subsequently, a mutant strain of L. lactis NZ9000 was made 
in which, apart from galP, also the downstream genes of the operon, galM and galK, 
were deleted (Fig. 2). Deletion of galPMK resulted in total loss of the capacity to 
grow in a medium with galactose as the sole source of carbon (Fig. 2), 
demonstrating that in the galP deletion strain another non-PTS system takes over 
the role of GalP.  
Besides non-PTS galactose transport, galactose can be imported via a PEP:PTS. 
Introduction of plasmid pMG820 (106) with genes lacABCDFEG encoding the 
lactose-PTS system and the tagatose-6-phosphate pathway enzymes (210) in L. 
lactis NZ9000ΔgalPMK, re-established the capability of the strain to use galactose. 
The lactose-PTS encoded by lacFE on pMG820 is a good candidate for a transport 
system able to import galactose, next to its usual substrate lactose (1, 148). It is 
unlikely that another galactose-transporting PTS is encoded on pMG820. Recently, 
sequence analysis of pLP712 ((52), of which pMG820 is a 23,7-kb deletion 
derivative) indeed revealed that no other sugar transporter is encoded by pMG820 
(personal communication: U. Wegmann, Institute of Food Research, Norwich 
Research Park, Norwich, UK). To be sure that LacFE was the galactose-PTS 
transporter, we furthermore had to rule out the possibility that another galactose-
PTS gene encoded by the chromosome of L. lactis MG1363, of which the activity 
only visualizes after introduction of the tagatose-6-phosphate pathway genes 
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lacABCD located on pMG820. Based on genome mining efforts there is no 
additional candidate gene encoding a galactose-specific PTS (215). This is the more 
unlikely since galactose imported via such a PTS would result in intracellular 
accumulation of Gal6P, which is highly toxic when it is not further metabolized, 
because a functional tagatose-6P pathway is not encoded by the L. lactis MG1363 
chromosome, but by pMG820. From recent results we can conclude that galactose 
is indeed transported via LacFE, since L. lactis NZ9000ΔgalPMK overexpressing the 
genes lacABCDFE could metabolize galactose, while NZ9000ΔgalPMK 
overexpressing only lacFE or lacABCD could not (A.R. Neves, Instituto de 
Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal, 




galP galM galK galT galE































Figure 2: L. lactis deletion strains used in this study and their growth characteristics. 
Top: Schematic overview of the genetic make up of the galP and galPMK deletion strains. 
Hooked arrow, promoter; lollipop, possible terminator structure. Genes are indicated by black 
arrows; grey regions, parts of the chromosome removed by the double cross-over deletion 
events; dashed parts, out of frame in the deletion strain. Bottom: Growth curve of L. lactis 
strains NZ9000, NZ9000ΔgalP and NZ9000ΔgalPMK in CDM with 1.0% galactose; 
corresponding maximum growth rates are given on the right. For L. lactis NZ9000ΔgalP the 
first μmax is calculated for the first 3 hours of growth, the second is calculated for the growth 
after 3 hours. The average of 2 experiments is shown. Differences did not exceed 5%. 
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Taken the above into account, galactose uptake in L. lactis 
NZ9000ΔgalPMK[pMG820] takes place via the PTS encoded by lacFE. Gal6P is 
subsequently further metabolized via the tagatose-6-phosphate pathway, encoded 
by lacABCD. Indeed, in vivo NMR on this strain shows accumulation of the typical 
tagatose-6-phosphate pathway intermediate tagatose-1,6-bisphosphate (TBP) (see 
below). Galactose consumption via the PEP:PTS (LacFE) was analyzed in L. lactis 
NZ9000ΔgalPMK[pMG820] without background effects of the Leloir pathway. 
 
 
Galactose consumption rate via the Leloir pathway is higher than via 
the PTS-uptake and subsequent tagatose-6-phosphate pathway in L. 
lactis 
Galactose consumption, end-product formation and the dynamics of intracellular 
metabolites derived from galactose in L. lactis strains NZ9000, NZ9000ΔgalP, and 
NZ9000ΔgalPMK[pMG820] were monitored by in vivo NMR (Fig. 3), to determine 
the galactose metabolic pathway used in each strain and their galactose 
consumption rates.  
L. lactis NZ9000 accumulated Gal1P and G1P, showing that galactose was 
consumed via the Leloir pathway and that galactose was imported via a non-PTS 
permease. The galactose consumption rate in L. lactis NZ9000 was 0.16 μmol·min-
1·mg protein-1. As also shown above, L. lactis NZ9000ΔgalP could still metabolize 
galactose, although the galactose consumption rate of this strain was much lower 
than when galP was present, i.e. only 0.09 μmol·min-1·mg protein-1. Slight 
accumulation of the intracellular metabolites Gal1P and G1P was detected in L. 
lactis NZ9000ΔgalP cells in vivo by NMR, indicating that the Leloir pathway was 
used for galactose metabolism. As galactose cannot be transported via GalP in this 
strain another, yet unknown, galactose non-PTS permease has to be active in L. 
lactis NZ9000ΔgalP to import galactose. Mining of the L. lactis MG1363 genome 
revealed no clear candidate gene coding for this non-PTS galactose transport 








































































































































































































































































Figure 3: Analysis of L. lactis galactose consumption.  
Galactose consumption and analysis of extracellular (A, C, E) en intracellular (B, D, F) 
metabolites by in vivo NMR of L. lactis strains NZ9000 (A, B), NZ9000ΔgalP (C, D) and 
NZ9000ΔgalPMK[pMG820] (E, F). For each strain the galactose consumption rate (GalCR) is 
depicted in μmol·min-1·mg protein-1. 
Chapter 4 
96 
L. lactis NZ9000ΔgalPMK[pMG820] could metabolize galactose, although no Gal1P 
nor G1P was detected in this strain. The strain accumulated TBP labelled at C1 
already 2 min. after galactose addition (Fig. 4), indicating that galactose is 
metabolized via the tagatose-6-phosphate pathway and that galactose is 
internalized via a PTS. After about 6 min. some FBP labelled at C6 is detected, 
caused by scrambling of the labelled carbon atom at the level of triose phosphate 
isomerase. This FBP arises from the triose phosphates (dihydroxyacetone 
phosphate and glyceraldehyde-3-phosphate) by the reverse reaction of fructose-
bisphosphate aldolase. The galactose consumption rate in L. lactis 
NZ9000ΔgalPMK[pMG820], which only uses a galactose PTS for galactose 
transport, was 0.05 μmol·min-1·mg protein-1. This is considerably lower than the 
galactose consumption rates in the strains that use the Leloir pathway. 
 
















































Figure 4: 13C-NMR spectra of L. lactis strains using [1-13C]-galactose.  
Spectra obtained during the metabolism of 20 mM galactose in L. lactis strains NZ9000 (A & 
B) and NZ9000ΔgalPMK[pMG820] (C & D) at time intervals 2.0-2.5 min (A & C) and 6.0-6.5 
min (B & D). L. lactis NZ9000 accumulates galactose-1-phosphate (Gal1P) and glucose-1-
phosphate (G1P) as shown in spectrum B, while NZ9000ΔgalPMK[pMG820] shows a 
resonance at 66.4 ppm assigned as [1-13C]-tagatose-bis-phosphate (TBP), already after 2 
min. Later also [6-13C]-fructose-bisphosphate (FBP) is shown. 
Galactose metabolism 
97 
Overexpression of Leloir genes in L. lactis results in accumulation of 
the intermediates Gal1P and G1P  
Since galactose metabolism via GalP and the Leloir pathway displayed the highest 
galactose consumption rate, overexpression of several combinations of Leloir 
pathway genes was examined to try to increase the galactose consumption rate. 
The galP gene alone and galP together with galMKT were cloned in pNG8048e, 
downstream of the nisin-inducible promoter, and the resulting vectors were 
introduced in L. lactis NZ9000. Overexpression of the Gal proteins was confirmed by 
SDS-PAGE and Coomassie Brilliant Blue staining (data not shown). Overexpression 
of galP or galPMKT resulted in lower growth rates on galactose than the empty-
vector control strain L. lactis NZ9000[pNZ8048]. Addition of more nisin to the cells 
with the galP or galPMKT overexpression plasmids decreased the growth rates even 
more (data not shown), an effect that was not observed with the control plasmid 
without the gal genes. Further analysis by in vivo NMR revealed, especially in L. 
lactis NZ9000 overexpressing galPMKT, a high accumulation of the Leloir pathway 
intermediates Gal1P (up to 24 mM) and G1P (up to 34 mM) (Fig. 5A & 5B). High 
intracellular concentrations of these phosphorylated intermediates could be toxic 
and suggests that a bottleneck exists in galactose metabolism at the level of α-PGM 
(see Fig. 1).  
 
 
Overexpression of α-phosphoglucomutase from S. thermophilus in L. 
lactis leads to faster galactose consumption 
The following step was to overexpress the gene encoding α-PGM, together with the 
genes of the Leloir pathway, to obtain better galactose consumption by a “push-and-
pull” strategy. Since the gene encoding α-PGM in L. lactis was not known at the 
time, the gene encoding α-PGM of S. thermophilus strain ST11 (pgmA-ST) was 
used as an alternative to increase the α-PGM activity in L. lactis. The pgmA-ST 
gene was amplified by PCR and overexpressed alone or downstream of galP or 
galPMKT in nisin-inducible plasmids in L. lactis NZ9000. Overexpression of S. 
thermophilus pgmA alone resulted in an approximately forty-fold increased α-
phosphoglucomutase enzymatic activity in L. lactis (Table 3), showing that the S. 
thermophilus enzyme is functional in L. lactis. Overexpression of S. thermophilus 
pgmA transcriptionally fused downstream of galPMKT led to a ten-fold increased α-
PGM activity, compared to the empty vector control L. lactis NZ9000[pNZ8048] 








































































































































































Figure 5: Galactose consumption and analysis of the intracellular intermediates Gal1P 
and G1P in different L.lactis strains analyzed by in vivo NMR.  
L. lactis strains examined: A) NZ9000[pgalP], B) NZ9000[pgalPMKT], C) NZ9000[ppgmA-ST], 
D) NZ9000[pgalP-pgmA-ST], E) NZ9000[pgalPMKT-pgmA-ST]. Galactose, galactose-1-
phosphate (Gal1P) and glucose-1-phosphate (G1P) concentrations are depicted for each 
strain. Other intracellular metabolites like fructose-1,6-bisphosphate, phosphoenolpyruvate 
and 2-phosphoglycerate and the external end-products lactate, ethanol, acetate and 2,3-
butanediol were detected but are omitted from the graphs for reasons of clarity. Galactose 
consumption rates (GalCR, in μmol·min-1·mg protein-1) are indicated for each strain in the table 
at the bottom right. 
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TABLE 3: Nisin-inducible α-phosphoglucomutase activity in L. lactis strains used in 
this study 
 
     α-Phosphoglucomutase activity (U/mg protein) 
Strain Not induced Nisin-induced  Overexpressiona) 
NZ9000[pNZ8048] 0.3   0.2     no 
NZ9000[ppgmA-ST] 0.4 15.9 ~ 40 x 
NZ9000[pgalPMKT-pgmA-ST]  0.3   2.9 ~ 10 x 
 
 
a) Nisin-induced overexpression, calculated from: value “not induced” / value “nisin-induced” 
 
 
The metabolism of galactose in L. lactis strains overexpressing pgmA-ST alone or 
together with galP or galPMKT was analyzed in vivo by NMR. All strains showed a 
mixed-acid fermentation, in which besides lactate, millimolar amounts of ethanol, 
acetate and 2,3-butanediol were formed (data not shown). A temporary 
accumulation of FBP was observed and 3PGA and PEP accumulated at the end of 
metabolism (data not shown). In Fig. 5 (panels C, D & E) galactose consumption 
and the concentrations of Gal1P and G1P in the three different pgmA-ST 
overexpressing strains are depicted. Overexpression of pgmA-ST alone or together 
with galP or galPMKT decreased the accumulation of Gal1P and G1P, previously 
observed in strains over-expressing galP(MKT) alone (Fig. 5). The galactose 
consumption rates in the strains overexpressing pgmA-ST together with galP(MKT) 






To improve galactose utilization in L. lactis, the first steps in galactose utilization 
were analyzed, to see which of the metabolic routes, the Leloir pathway or the 
plasmid-introduced tagatose-6-phosphate pathway, was the most efficient. Gene 
galP, encoding a galactose non-PTS transporter (the first step of the Leloir 
pathway), was removed from the chromosome in order to be able to examine the 
plasmid pMG820-encoded tagatose-6-phosphate pathway. Surprisingly, and in 
conflict with previous results (54), a strain in which the known galactose permease 
GalP had been removed was still able to grow on galactose. We suspect that the 
galP deletion previously described (54) had a downstream negative effect, although 
significant GalK activity was detected, disturbing the maximal activity of the Leloir 
enzymes, leading to the strongly reduced galactose uptake and metabolism 
detected. Our strain L. lactis NZ9000ΔgalP used galactose via the Leloir pathway, 
as the typical Leloir intermediates Gal1P and G1P were detected in L. lactis 
NZ9000ΔgalP. This could not be caused by residual activity of GalP, as an out-of-
frame deletion was made in which only the first four amino acids of the original 
protein are left. Based on these results we conclude that, next to GalP, at least one 
more efficient non-PTS galactose transporter has to be encoded by the genome of 
L. lactis NZ9000. Inspection of the genome sequence of L. lactis MG1363, the 
parent of strain NZ9000, however, did not yield an obvious candidate gene.  
Since deletion of galP resulted in a galactose consumption rate that was almost half 
of that of the L. lactis NZ9000, galactose consumption is most efficient when GalP is 
used for galactose transport. In L. lactis NZ9000ΔgalP, the maximum galactose 
consumption rate is decreased to 0.09 μmol·min-1·mg protein-1 from 0.16 μmol·min-
1·mg protein-1 for L. lactis NZ9000.  
A complete block of galactose metabolism was obtained by deletion of chromosomal 
galPMK. Although galactose may still be imported via the unidentified putative 
galactose permease, further conversions should be hindered, since galactose 
mutarotase (GalM) and galactose kinase (GalK) are not present in the triple gal 
mutant. The data allows concluding that at least one of these two enzymes (GalM or 
GalK) has no homologue in L. lactis.  
With the introduction of pMG820 in L. lactis NZ9000ΔgalPMK, the ability of the strain 
to metabolize galactose was re-established. In L. lactis NZ9000ΔgalPMK[pMG820] 
galactose is imported via the plasmid-encoded PTS (LacFE), resulting in Gal6P, 
which is further metabolized through the tagatose-6P-pathway (LacABCD). Indeed, 
during galactose fermentation a slight accumulation of the pathway’s intermediate 
Galactose metabolism 
101 
TBP was observed by in vivo NMR. Although sugar transport via a PTS is 
bioenergetically favourable for L. lactis, since only one ATP is spent on transport 
and phoshorylation of the sugar, the in vivo analyses of galactose metabolism 
presented here reveal that L. lactis using a PTS in combination with the tagatose-
6P-pathway did not reach the same galactose consumption rate as did an L. lactis 
strain employing a non-PTS galactose permease followed by the Leloir pathway.  
Of course this may be largely caused by the possibility that the PTS encoded by 
pMG820 has a low affinity for galactose. We conclude that improvement of L. lactis 
galactose metabolism via engineering of the Leloir pathway using GalP seems the 
most viable route, when self-cloning techniques are preferred over heterologous 
expression of genes. 
Since accumulation of Gal1P and G1P occurred in the galP(MKT) overexpressing 
strains, the bottleneck in galactose metabolism via the Leloir pathway was shown to 
be at the level of α-PGM. Heterologous overexpression of the pgmA gene of S. 
thermophilus in L. lactis NZ9000 increased the α-PGM activity. Overexpression of 
this true α-PGM of S. thermophilus together with the L. lactis Leloir genes relieved 
the galactose metabolic bottleneck and improved the galactose consumption rate 
significantly.  
In summary, we can conclude that galactose is consumed in L. lactis most efficiently 
via the Leloir pathway using GalP as a permease, and that galactose transport by 
lacFE followed by tagatose-6-phosphate pathway activity is less efficient. Moreover, 
α-PGM appears to be a key enzyme in controlling the galactose metabolic flux, 
especially when the first steps in the Leloir pathway are overexpressed. Recently, α-
PGM of L. lactis MG1363 was identified and interestingly shown to be related to the 
eukaryotic phosphomannomutases within the haloacid dehalogenase superfamily 
(121). Overexpression of galP(MKT) together with pgmA-ST in L. lactis NZ9000 
increased the galactose consumption rate significantly to 0.23 μmol·min-1·mg 
protein-1 compared to 0.16 μmol·min-1·mg protein-1 in wildtype NZ9000. At this point, 
we do not know whether the strain described in this chapter will leave less residual 
galactose during a milk fermentation. Further improvement of galactose 
consumption may require even more sophisticated strategies like engineering of 
regulatory genes, as was done for Saccharomyces cerevisiae (131). It has been 
shown that the galactose genes in L. lactis are repressed by the carbon catabolite 
control protein CcpA when a more favourable sugar like glucose is present (105, 
225). To improve galactose utilization independent of environmental conditions, 
engineering could be focussed on these regulatory pathways, to possibly engineer a 
strain preferring galactose over glucose. It would also be interesting to introduce 
pgalP(MKT)-pgmA-ST (the plasmid carrying galP(MKT) together with pgmA of S. 
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thermophilus behind the nisin promoter) in the glucose-negative strain (L. lactis 
NZ9000ΔglkΔptnABCDΔptcBA, Chapter 2, (141)). This strain, with its combination of 
genetically engineered traits (it is blocked in glucose metabolism and improved for 
galactose metabolism), would in theory be a very interesting candidate for analysis 
of residual galactose, especially in an experimental dairy fermentation using a 
combination of sugar substrates.  
 
 
 
 
